Annual Report To Shareholders and AGM Notice

/in , /by

Prophecy released its Annual Report and Notice of AGM to the Australian Stock Exchange on 24 October 2016

2016_PIHL_AGM

2016_PIHL_AnnualReport

Securities Trading Policy

/in , /by

Prophecy released its updated Securities Trading policy to the ASX on 13 October 2016

09 PRO Corp Governance – Securities Trading Policy

The full set of Prophecy’s Corporate Governance Policies can be found here

Appendix 3Y Change of Director’s Interests

/in /by

PIHL_Appendix_3Y_2016_09_26

Full Year 2016 Statutory Accounts

/in , /by

PIHL_FY2016_Statutory_Accounts

Appendix 3Y Change of Director’s Interest

/in /by

PIHL_Appendix_3Y_2016_09_20

Brad Thomas OAM joins eMite

/in , /by

eMite is pleased to announce the appointment of Brad Thomas in the new position of General Manager Sales. eMite is poised to move into a rapid growth phase through increased sales, as experienced in recent years by the Prophecy stable’s SNARE products. The SNARE business has expanded its Denver sales office to 12 staff and a similar growth is planned for eMite. Brad Thomas has the objective to build a similarly sized sales team within eMite to capture the growth potential of the eMite product set.

Brad has most recently been a Senior General Manager and Head of Sales at Canon Australia, leading large teams across direct and indirect sales, service delivery and professional services. He has 20+ years’ experience in growing businesses across Australia, New Zealand,  Asia Pacific and Japan.

Brad’s strategy and leadership experience spans sales, marketing, service delivery and operations with strategic growth know-how developed across companies such as Microsoft, Canon, Novell, Lenovo and Telstra in software, print, managed services, telecommunications and IT hardware. His business growth experience encompasses start-ups and SMEs to corporates and multinationals. Brad is known by industry and peers for partner and channel management and programs, go to market strategy, sales leadership and motivational speaking.

Brad’s methodologies are recognised for growing revenue, profit and staff engagement.  At Canon, he successfully led and developed new go to market strategies, built new sales teams, rebuilt and turned around channels sales teams and partner programs and established new channels to market as well as established sales effectiveness and sales enablement programs.

Brad partners with the board in developing vision, strategy and organisational goals. His core focus on growth includes efficiency of  sales organisations and  partner ecosystems, clear go to market strategies and unique value propositions,  together with  direct alignment between sales and marketing. Across his career Brad has been instrumental in attaining stretch KPIs, profit and margin growth, market share and business efficiencies.

His specialist expertise includes strategy, leadership, sales, business alliances, marketing, partner management, public speaking, operational management, service delivery and cross functional engagement.

We all welcome Brad Thomas into this senior role within the Prophecy group and look forward to positive change and growth within the eMite business as a result.

Prophecy Presentation on FY2016 Full Year Results

/in , /by

Prophecy Presentation Full Year 2016

Dividend Notification 24 August 2016

/in , /by

Dividend Distribution Notification 24 Aug 16

Preliminary Final Report for Year Ended 30 June 2016

/in , /by

Company Announcement 18 August 2016

 

PIHL_Preliminary_Final_Report_2016

FY16 Record Results

/in , /by

Company Announcement 26th July, 2016

  • Full year FY16 EBITDA: a record at $5.0 million, up 13%
  • Full year revenue: a record at $14.7 million, up 47%
  • Q4 new sales: up 62% from Q3, a very pleasing improvement
  • SNARE Q4 new sales: best quarter for the year
  • SNARE full year revenue: up 28% to $7.6 million, a record
  • Improved sales result expected to flow into FY17

Prophecy’s EBITDA for FY16 is expected to be $5.0m once audited accounts are complete. This earnings result is a new record for the group, and shows growth of 13% compared to FY15 EBITDA. The Board is very pleased with this full year result.
FY16 revenue has come in at $14.7 million. This figure represents a new revenue record for the group, and is up a healthy 47% compared to FY15.
A portion of invoiced new sales is allocated to income in advance, with the rest taken up as current revenue in FY16. Income in advance is made up primarily of future maintenance commitments and consulting ordered but not yet performed. The percentage of new sales taken up as income in advance as higher than forecast, resulting in the recognised revenue from FY2016 new sales being lower than expected. As a result, income in advance has grown to $3.4m at the end of FY16, compared to $1.8m at the end of FY15. This income in advance figure represents guaranteed revenue for the future, with most to be taken to account during FY2017.

It is pleasing to be able to report that FY16 Q4 new sales results were very strong compared to the previous two quarters. Q4 new sales across the group were up by 62% from the Q3 total, and 44% from the Q2 total. Q1 remained as the best new sales quarter overall for the FY16 year.
In the SNARE division, Q4 provided the best quarterly sales result in the year, beating Q3 by 64%, Q2 by 35% and Q1 by 10%. The full year SNARE new sales figures grew by 13% compared to FY15. SNARE total recognised revenue for FY16 came in at a new record $7.6 million, compared to $5.9 million in FY15. This result provided excellent overall SNARE revenue growth of 28% for the full year. The SNARE team has been structured to target continued further growth through FY17.
eMite sales for Q4 finished 55% up on the Q3 result. eMite staff attended the Interactive Intelligence (ININ) user conference in Indianapolis in early June and were able to gain a tremendous interest in the eMite analytics solution for ININ users. The eMite solution was very well received by both ININ staff and customers and has generated a large volume of leads for sales action in FY17. A much improved sales result is expected for eMite in FY17 as a result of the foundation laid in FY16.
The improved sales result is expected to flow into FY17 Q1 new sales with a very healthy pipeline in place for both SNARE and eMite. New sales activity has accelerated as a result of the recent improved sales process. New sales resources have come on board to enhance the SNARE sales team and additional resource is currently being sought for the eMite team to capitalise on the improved results.